Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD on Microglial Activation and Central Pain-Sensitization
NCT04398719Phase 1Completed
- Sponsor
- Yale University
- Start
- May 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in pain comparing CBD with Placebo (2 arms). Primary endpoint: Microglial activation using [11C]PBR28 PET imaging at 10 days. Started May 2021; status: completed.
02
Drugs
cannabidiol
03
Conditions
pain
Beyond the preview
Go deeper on NCT04398719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04398719.